| Literature DB >> 30597229 |
Xiaojie Yang1, Shiyue Zhou2, Jiaojiao Wu3, Qun Liao4, Changquan Wang5, Minghua Liu6, Lei Qu7, Yuan Zhang8, Cheng Cheng9, Renjie Chai10, Kun Zhang11, Xiaojie Yu12, Pingbo Huang13, Lian Liu14, Wei Xiong15, Shi Chen16, Fangyi Chen17.
Abstract
Vestibulo-ocular reflex (VOR) responding to acceleration stimuli is originated from the vestibular apparatuses and thus widely used as an in vivo indicator of the vestibular function. We have developed a vestibular function testing (VFT) system that allows to evaluate VOR response with improved efficiency. The previously required surgical procedure has been avoided by using a newly designed animal-immobility setup. The efficacy of our VFT system was demonstrated on the mice with vestibular abnormalities caused by either genetic mutations (Lhfpl5-/- or Cdh23-/-) or applied vestibulotoxicant (3,3'-iminodipropionitrile, IDPN). Daily longitudinal inspection of the VOR response in the IDPN-administered mice gives the first VOR-based daily-progression profile of the vestibular impairment. The capability of VOR in quantifying the severity of toxicant-induced vestibular deficits has been also demonstrated. The acquired VOR-measurement results were validated against the corresponding behavioral-test results. Further validation against immunofluorescence microscopy was applied to the VOR data obtained from the IDPN-administered mice. We conclude that the improved efficiency of our surgery-free VFT system, firstly, enables the characterization of VOR temporal dynamics and quantification of vestibular-impairment severity that may reveal useful information in toxicological and/or pharmaceutical studies; and, secondly, confers our system promising potential to serve as a high-throughput screener for identifying genes and drugs that affect vestibular function.Entities:
Keywords: 3,3′-iminodipropionitrile (IDPN); Behavioral assay; Genetic screen; Mouse model; Ototoxicity; Vestibular function; Vestibulo-ocular reflex (VOR); Video-oculography (VOG)
Mesh:
Substances:
Year: 2018 PMID: 30597229 DOI: 10.1016/j.neulet.2018.12.036
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046